Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
11.69
-0.20 (-1.68%)
Feb 11, 2025, 11:52 AM EST - Market open
DAWN Employees
Day One Biopharmaceuticals had 155 employees as of December 31, 2023. The number of employees increased by 34 or 28.10% compared to the previous year.
Employees
155
Change (1Y)
34
Growth (1Y)
28.10%
Revenue / Employee
$657,761
Profits / Employee
-$543,826
Market Cap
1.18B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 155 | 34 | 28.10% |
| Dec 31, 2022 | 121 | 66 | 120.00% |
| Dec 31, 2021 | 55 | 35 | 175.00% |
| Dec 31, 2020 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
DAWN News
- 5 weeks ago - Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5) - Seeking Alpha
- 6 weeks ago - Day One Biopharmaceuticals: Sales Figures In The Crosshairs - Seeking Alpha
- 2 months ago - Day One to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development - GlobeNewsWire
- 3 months ago - Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Day One Biopharmaceuticals, Inc. (DAWN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Day One Reports Third Quarter 2024 Financial Results and Corporate Progress - GlobeNewsWire
- 4 months ago - Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024 - GlobeNewsWire